- POSTPONED-May 18 & 19, North/South Dakota
- June 23, 2016-Boston, MA
- September 30, 2016-NYC Women & MPN
- View videos from San Mateo
Sign up for our Newsletter: MPN Community Connection
We are pleased to bring you our new monthly newsletter. Stay informed and updated on issues related to myeloproliferative neoplasms (MPNs): myelofibrosis, polycythemia vera and essential thrombocythemia via monthly email.Sign Up Now
We keep you informed of MPN-related Clinical Trial Updates and News:
Get the latest news on MPN research, clinical trials, treatments, education, and advocacy.
- Incyte Announces Presentations at ASCO
- CTI-BioPharma Announces Presentations at ASCO
- Myelofibrosis and acquired hemophilia A: a case report
- Drug-like Peptides Show Promise in Treating PV
- Ariad Pharmaceuticals agrees to sell European operations to Incyte
- Calreticulin Mutation Analysis in Iranian Patients
Patient & Caregiver Support
Join with other patients to learn more about your disease and treatment options through an in-person or online support group. Many major cities throughout the United States and internationally host regular meetings. Contact Ann Brazeau if you are interested in establishing a new Support Group for your area : 517.899.6889 firstname.lastname@example.orgLearn More
Our scientific advisor is Dr. Ruben Mesa of the Mayo Clinic. He is a frequent speaker at our events. Read more about Dr. Mesa.
Free Patient Info Pack
Give us your address and we’ll send you a free informational package in the mail. Your contact information will be kept strictly confidential. Sign Up Now
What is a myeloproliferative neoplasm? MPNs are a group of rare blood cancers that overproduce blood cells in the bone marrow, and are caused by genetic mutations in the blood stem cells:
- Myelofibrosis is a rare bone marrow cancer. Bone marrow cells that produce blood cells develop and function abnormally resulting in fibrous scar tissue formation.
- Polycythemia Vera is a disorder in which the bone marrow makes too many red blood cells. It may also result in the production of too many other types of blood cells – white blood cells and platelets.
- Essential Thrombocythemia causes the body to produce too many blood platelets-thrombocytes. It can cause abnormal clotting or bleeding. The bone marrow makes too many platelet-forming cells or megakaryocytes, which release platelets into your blood.